Journal of Life Science (생명과학회지)

Korean Society of Life Science (한국생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Vascular Smooth Muscle Cells Secrete CXCL10 in Response to Heat Shock Protein 90

혈관평활근세포에서 HSP90에 의한 CXCL10 증가에 관여하는 인자에 대한 연구

  • Rhim, Byung-Yong (Department of Pharmacology, School of Medicine, Pusan National University) ;
  • Kim, Do-Hyung (Department of Pharmacology, School of Medicine, Pusan National University) ;
  • Kim, Koan-Hoi (Department of Pharmacology, School of Medicine, Pusan National University)
  • 임병용 (부산대학교 의학전문대학원 약리학교실) ;
  • 김도형 (부산대학교 의학전문대학원 약리학교실) ;
  • 김관회 (부산대학교 의학전문대학원 약리학교실)
  • Received : 2011.03.19
  • Accepted : 2011.04.08
  • Published : 2011.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Oxidative stress results in sustained release of heat shock protein 90 (HSP90) from vascular smooth muscle cells (VSMCs). We investigated whether extracellular HSP90 predisposed VSMCs to pro-inflammatory phenotype. Exposure of human aortic smooth muscle cells to HSP90 not only significantly enhanced CXCL10 secretion but also increased CXCL10 transcription. HSP90-mediated CXCL10 secretion was attenuated by OxPAPC, a TLR-2/4 inhibitor, and curcumin, a TLR-4 dimerization inhibitor. Inhibitors of diphenyleneiodium chloride and the Akt pathway also attenuated CXCL10 secretion in response to HSP90. The gene delivery of I${\kappa}$B using recombinant adenoviruses and treatment with resveratrol, which inhibit NF-${\kappa}$B activity, significantly attenuated HSP90-induced CXCL10 secretion from VSMCs. We propose that extracellular HSP90 contributes to an inflammatory reaction in the stressed vasculature by inducing CXCL10 expression of VSMCs, and that TLR-4, Akt, and NF-${\kappa}$B play active roles in the process.

Heat shock protein (HSP)은 외부적인 자극에 반응하여 세포를 보호하는 역할을 한다. 또한 HSP90은 혈관질환에서 처럼 세포가 사멸되거나 손상을 입는 경우 세포 밖으로 유리된다. 그러나 지금까지 세포 밖 HSP90이 혈관평활근세포에 어떠한 영향을 주는지에 대한 연구는 미약하다. 따라서 본 연구는 혈관평활근세포에서 HSP90이 CXCL10 발현에 대한 영향과 그 기전을 규명하였다. HSP90에 노출된 혈관평활근세포에서 CXCL10 transcript가 증가하고, CXCL10 단백질의 분비가 증가되었다. HSP90에 의한 CXCL10 분비는 Toll-like receptor (TLR)-2/-4 억제제인 1-palmitoyl-2-arachidonosyl-sn-phosphatidylcholine (OxPAPC)과 NADPH oxidase 억제제인 diphenyleneiodium 그리고 Akt 경로를 억제하는 LY294002와 Akti IV에 의하여 크게 감소되었다. 또한 TLR-4의 dimerization을 저해하는 curcumin 역시 HSP90에 의한 CXCL10의 분비를 억제하였다. 전사인자인 nuclear factor kappa B(NF-${\kappa}$B)의 생물학적 억제제인 inhibitory kappa B (I${\kappa}$B)와 NF-${\kappa}$B 억제작용이 있는 rasveratrol은 HSP90에 의한 CXCL10 분비를 억제하였다. 이러한 결과는 혈관평활근세포에서 HSP90에 의한 CXCL10의 발현에 TLR-4와 Akt 및 NF-${\kappa}$B가 관여함을 의미한다.

Keywords

References

  1. Akira, S. and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511. https://doi.org/10.1038/nri1391
  2. Basu, S., R. J. Binder, R. Suto, K. M. Anderson, and P. K. Srivastava. 2000. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int. Immunol. 12, 1539-1546. https://doi.org/10.1093/intimm/12.11.1539
  3. Fujii, H., Y. Shimada, M. Hasegawa, K. Takehara, and S. Sato. 2004. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis. J. Dermatol. Sci. 35, 43-51. https://doi.org/10.1016/j.jdermsci.2004.03.001
  4. Hanaoka, R., T. Kasama, M. Muramatsu, N. Yajima, F. Shiozawa, Y. Miwa, M. Negishi, H. Ide, H. Miyaoka, H. Uchida, and M. Adachi. 2003. A novel mechanism for the regulation of IFN-gamma inducible protein-10 expression in rheumatoid arthritis. Arthritis Res. Ther. 5, R74-81. https://doi.org/10.1186/ar616
  5. Hollestelle, S. C., M. R. De Vries, J. K. Van Keulen, A. H. Schoneveld, A. Vink, C. F. Strijder, B. J. Van Middelaar, G.Pasterkamp, P. H. Quax, and D. P. De Kleijn. 2004. Toll-like receptor 4 is involved in outward arterial remodeling. Circulation 109, 393-398. https://doi.org/10.1161/01.CIR.0000109140.51366.72
  6. Jinquan, T., C. Jing, H. H. Jacobi, C. M. Reimert, A. Millner, S. Quan, J. B. Hansen, S. Dissing, H. J. Malling, P. S. Skov, and L. K. Poulsen. 2000. CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma. J. Immunol. 165, 1548-1556. https://doi.org/10.4049/jimmunol.165.3.1548
  7. Liao, D. F., Z. G. Jin, A. S. Baas, G. Daum, S. P. Gygi, R. Aebersold, and B. C. Berk. 2000. Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J. Biol. Chem. 275, 189-196. https://doi.org/10.1074/jbc.275.1.189
  8. Libby, P. 2002. Inflammation in atherosclerosis. Nature 420, 868-874. https://doi.org/10.1038/nature01323
  9. Luster, A. D. and J. V. Ravetch. 1987. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J. Exp. Med. 166, 1084-1097. https://doi.org/10.1084/jem.166.4.1084
  10. Manning, B. D. and L. C. Cantley. 2007. AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274. https://doi.org/10.1016/j.cell.2007.06.009
  11. Michelsen, K. S., M. H. Wong, P. K. Shah, W. Zhang, J. Yano, T. M. Doherty, S. Akira, T. B. Rajavashisth, and M. Arditi. 2004. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. USA 101, 10679-10684. https://doi.org/10.1073/pnas.0403249101
  12. Narumi, S., T. Takeuchi, Y. Kobayashi, and K. Konishi. 2000. Serum levels of interferon-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus. Cytokine 12, 1561-1565. https://doi.org/10.1006/cyto.2000.0757
  13. Park, H. S., H. Y. Jung, E. Y. Park, J. Kim, W. J. Lee, and Y. S. Bae. 2004. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide- induced production of reactive oxygen species and activation of NF-kappa B. J. Immunol. 173, 3589-3593. https://doi.org/10.4049/jimmunol.173.6.3589
  14. Pockley, A. G. 2003. Heat shock proteins as regulators of the immune response. Lancet 362, 469-476. https://doi.org/10.1016/S0140-6736(03)14075-5
  15. Rotondi, M., L. Chiovato, S. Romagnani, M. Serio, and P. Romagnani. 2007. Role of chemokines in endocrine autoimmune diseases. Endocr. Rev. 28, 492-520. https://doi.org/10.1210/er.2006-0044
  16. Singh, S. and B. B. Aggarwal. 1995. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J. Biol. Chem. 270, 24995-25000. https://doi.org/10.1074/jbc.270.42.24995
  17. Sorensen, T. L., M. Tani, J. Jensen, V. Pierce, C. Lucchinetti, V. A. Folcik, S. Qin, J. Rottman, F. Sellebjerg, R. M. Strieter, J. L. Frederiksen, and R. M. Ransohoff. 1999. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103, 807-815. https://doi.org/10.1172/JCI5150
  18. Srivastava, P. 2002. Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol. 2, 185-194. https://doi.org/10.1038/nri749
  19. Strieter, R. M., P. J. Polverini, S. L. Kunkel, D. A. Arenberg, M. D. Burdick, J. Kasper, J. Dzuiba, J. Van Damme, A. Walz, D. Marriott, and et al. 1995. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270, 27348-27357. https://doi.org/10.1074/jbc.270.45.27348
  20. Taub, D. D., A. R. Lloyd, K. Conlon, J. M. Wang, J. R. Ortaldo, A. Harada, K. Matsushima, D. J. Kelvin, and J. J. Oppenheim. 1993. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177, 1809-1814. https://doi.org/10.1084/jem.177.6.1809
  21. Whitley, D., S. P. Goldberg, and W. D. Jordan. 1999. Heat shock proteins: a review of the molecular chaperones. J. Vasc. Surg. 29, 748-751. https://doi.org/10.1016/S0741-5214(99)70329-0
  22. Yang, X., D. Coriolan, V. Murthy, K. Schultz, D. T. Golenbock, and D. Beasley. 2005. Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling. Am. J. Physiol. Heart Circ. Physiol. 289, H1069-1076. https://doi.org/10.1152/ajpheart.00143.2005
  23. Yang, X., D. Coriolan, K. Schultz, D. T. Golenbock, and D. Beasley. 2005. Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 25, 2308-2314. https://doi.org/10.1161/01.ATV.0000187468.00675.a3
  24. Youn, H. S., J. Y. Lee, K. A. Fitzgerald, H. A. Young, S. Akira, and D. H. Hwang. 2005. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J. Immunol. 175, 3339-3346. https://doi.org/10.4049/jimmunol.175.5.3339
  25. Youn, H. S., S. I. Saitoh, K. Miyake, and D. H. Hwang. 2006. Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem. Pharmacol. 72, 62-69. https://doi.org/10.1016/j.bcp.2006.03.022
  26. Zernecke, A., E. Shagdarsuren, and C. Weber. 2008. Chemokines in atherosclerosis: an update. Arterioscler. Thromb. Vasc. Biol. 28, 1897-1908. https://doi.org/10.1161/ATVBAHA.107.161174